Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure
Sign Up to like & getrecommendations! Published in 2019 at "Heart and Vessels"
DOI: 10.1007/s00380-019-01450-w
Abstract: Human atrial natriuretic peptide, known as carperitide, is approved for early relief of dyspnea in patients with acute heart failure (AHF). However, the diuretic effect of carperitide is sometimes insufficient for controlling volume overload. We… read more here.
Keywords: heart; low dose; carperitide; dose carperitide ... See more keywords